Elsevier Health Sciences


« Back to Resource Center

WHO Global Agenda for Influenza Surveillance and Control

Objectives of the Global Agenda

  • Provide impartial and prioritized guidance to all parties on research and development and national/global action for influenza control
  • Support co-ordination of action for influenza control and surveillance
  • Support implementation of identified priorities
  • Support advocacy and fund raising

The Global Agenda has been developed for all those involved in activities to:

  • Reduce morbidity and mortality from annual influenza epidemics
  • Prepare for the next influenza pandemic
  • Co-ordinate national and international action in influenza surveillance and control
  • Advocate and raise funds

Major Themes in the Global Agenda

  • 1. Improvement in the quality and coverage of virological and epidemiological influenza surveillance
  • 2. Improvement in the understanding of health and economic burden of influenza, including benefits from epidemic control and pandemic preparedness
  • 3. Expansion in the use of existing vaccines, particularly in developing countries and in high-risk groups and acceleration in the introduction of new vaccines
  • 4. Increase in national and global epidemic and pandemic preparedness, including vaccine and pharmaceutical supplies

Priority activities and key actions to reduce morbidity and mortality from annual influenza epidemics and to prepare for the next pandemic

A.. Strengthen virological and epidemiological surveillance nationally and internationally
  • i. Enhance and integrate virological and disease surveillance
  • ii. Expand virological and disease surveillance
  • iii. Expand animal influenza surveillance and integrate with human influenza surveillance
  • iv. Improve data management, utilization and exchange
B.. Increase knowledge on the health and economic burden of influenza
  • i. Strengthen the capacity in epidemiological and statistical techniques for studies on influenza disease burden
  • ii. Evaluate the clinical and economic burden of disease in countries where there is no recognition of influenza or no control policies are in place
  • iii. Re-evaluate the clinical and economic burden of influenza in countries where influenza control policies are in place
C.. Increase influenza vaccine usage
  • i. Encourage assessment of disease burden and cost-effectiveness analyses
  • ii. Encourage countries to establish national policies and set immunization targets
  • iii. Promote awareness among policy makers, health care providers, and the public
  • iv. Encourage countries to identify and develop effective strategies for vaccine delivery
  • v. Develop and implement methods for the measurement and feedback of the progress of national and local programmes
D.. Accelerate national and international action on pandemic preparedness
  • i. Increase awareness of the need for pandemic planning
  • ii. Accelerate the development and implementation of national pandemic plans
  • iii. Enhance the utilization of influenza vaccine and antivirals in the inter-pandemic period
  • iv. Develop strategies for the utilization of vaccines and antivirals and secure adequate supplies for a pandemic
  • v. Advocate research on pandemic viruses, vaccines, antivirals and other control measures

The Global Agenda on Influenza Surveillance and Control was developed and agreed by consensus by the participants of the WHO Consultation on Global Priorities in Influenza, World Health Organization, Geneva, Switzerland, 6–7 May 2002.

1 The full text of the WHO Global Agenda for Influenza Surveillance and Control can be found at:

« Back to Resource Center